McElla Pappas Weber

We’re seeing an alarming uptick in increasingly sophisticated recruiting scams - heres’s a PSA on how one of the latest iterations works: ✅ you receive an email purporting to be from a real recruiter at a real company 🚩 only when you scrutinize the email address you see that it’s actually a random gmail address ✅ the “recruiter” references parts of your LinkedIn profile and how these make you a good match for a job ✅ once you respond the recruiter sends you a link to a real job ✅ the “recruiter” then asks for your resume after you’ve expressed an interest in the real job 🚩 the “recruiter” then suggests that even small variances between your LinkedIn profile and your resume cast doubt on your ability to be successful 🚩 the “recruiter” then offers to connect you with a “professional resume writer for a small fee” to ensure that you’re a good match for the job ❌ real recruiters don’t contact you from gmail addresses ❌ real recruiters don’t create fear ❌ real recruiters NEVER refer you to paid services of any kind This is obviously really distressing for all concerned - please share widely and let me know ⬇️ of any other variants on this so that we can continue to raise awareness

140

34 Comments

🧠 𝐒𝐍𝐌𝐌𝐈 𝟐𝟎𝟐𝟓: 𝐑𝐚𝐝𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 𝐈𝐧𝐟𝐫𝐚𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐞 𝐒𝐡𝐢𝐟𝐭? The headlines this week at SNMMI are full of pipelines and alpha hype... But another story is playing out on the show floor: - Infrastructure is no longer a future constraint. - 𝐈𝐭’𝐬 𝐭𝐡𝐞 𝐩𝐫𝐞𝐬𝐞𝐧𝐭 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭𝐢𝐚𝐭𝐨𝐫 - 𝐩𝐥𝐚𝐲𝐢𝐧𝐠 𝐨𝐮𝐭 𝐛𝐨𝐨𝐭𝐡 𝐛𝐲 𝐛𝐨𝐨𝐭𝐡. Here’s a select few who are showing real hardware, shielding, and CDMO firepower this week: ➡️ Mirion Medical - launching the Instadose VUE Beta dosimeters & Graves Phantom QA tools ➡️ Trasis - demoing the integrated AllinOne synthesis + QC system ➡️ Comecer - presenting alpha-ready platforms, including ALCEO & MODUS ➡️ Eckert & Ziegler SE - showcasing shielding, isotope handling & CDMO support ➡️ Jubilant Radiopharma - pitching scalable PET/CDMO services ➡️ Tema Sinergie - known for shielded isolators and containment systems ➡️ SOFIE - expanding its FAPI theranostic CDMO footprint ➡️ NorthStar Medical Radioisotopes, LLC - extending isotope supply & CDMO infrastructure ➡️ Lemer Pax - rolling out high-throughput RLT preparation systems (e.g. Posijet®, Theranojet®ARA) ➡️ ABX advanced biochemical compounds GmbH - Highlighting modular synthesis systems (Modular-Lab), a core component of clinical supply. ➡️ Advanced Cyclotron Systems Inc. - Offering compact cyclotrons enabling regional isotope access. ➡️ BWXT (Medical/Nuclear) - Specializing in isotope production, hot cells, and advanced shielding solutions. ➡️ Radiomedix, Inc. - With their leadership team, highlighting their cGMP radiopharmaceutical manufacturing capabilities 🧭 𝐖𝐡𝐲 𝐭𝐡𝐢𝐬 𝐦𝐚𝐭𝐭𝐞𝐫𝐬 𝐧𝐨𝐰 ✅ It's not whiteboard planning - it’s booth-level demos transforming RLT buildout ✅ The differentiator? Who can build, qualify, shield, and scale - not just discover ✅ Radiopharma’s next few years will be defined by execution infrastructure, not pipeline promise 👇 𝐖𝐡𝐨 𝐞𝐥𝐬𝐞 𝐝𝐢𝐝 𝐲𝐨𝐮 𝐬𝐩𝐨𝐭 𝐛𝐮𝐢𝐥𝐝𝐢𝐧𝐠 𝐚𝐭 𝐒𝐍𝐌𝐌𝐈 𝟐𝟓? Tag them below - let's give this space the attention it deserves! #SNMMI2025 #Radiopharma #Theranostics #CDMO #Infrastructure #NuclearMedicine #Radiochemistry #Biotech #ProGenSearch

299

28 Comments

Drug Safety is one of the highest-stakes leadership hires a growing biotech will make. As programs advance and regulatory complexity increases, this role requires far more than pharmacovigilance expertise. It takes strategic leadership, strong cross-functional partnership, regulatory depth, and the ability to scale systems without ever losing sight of patient safety. We recently partnered with an innovative San Diego–based clinical-stage biotech to help secure this critical leader. The process was highly collaborative, with clear alignment on culture, stage, and long-term vision — exactly what it takes to get leadership hires right. Grateful for the trust. If you’re building or strengthening leadership across Drug Safety, Clinical, Regulatory, or Quality, let’s connect Thorough Group Sean Burroughs Michael Buckley Hari Dhurjaty Chad MacDonald Raquel Marquez

10

𝐉𝐚𝐧𝐮𝐚𝐫𝐲 𝐤𝐢𝐜𝐤𝐞𝐝 𝐨𝐟𝐟 𝐰𝐢𝐭𝐡 𝐚 𝐛𝐚𝐧𝐠 𝐢𝐧 𝐥𝐢𝐟𝐞 𝐬𝐜𝐢𝐞𝐧𝐜𝐞 𝐭𝐨𝐨𝐥𝐬 💥. There’s a lot of momentum right now, especially around product launches, and what’s striking is where innovation is coming from: not just the big players, but some seriously exciting smaller teams pushing the stack forward. 𝗔 𝗳𝗲𝘄 𝘁𝗵𝗲𝗺𝗲𝘀 𝗜 𝗹𝗼𝘃𝗲𝗱 𝗳𝗿𝗼𝗺 𝘁𝗵𝗶𝘀 𝗺𝗼𝗻𝘁𝗵’𝘀 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀: 🔎𝗦𝗶𝗻𝗴𝗹𝗲-𝗰𝗲𝗹𝗹 & 𝘀𝗽𝗮𝘁𝗶𝗮𝗹: 𝘮𝘰𝘳𝘦 𝘴𝘪𝘨𝘯𝘢𝘭 𝘧𝘳𝘰𝘮 𝘦𝘷𝘦𝘳𝘺 𝘤𝘦𝘭𝘭. We saw new depth and flexibility in workflows, with SeekGene BioSciences bringing epigenetics and transcriptomics together in a high-throughput single-cell multiomics workflow and RAN Biotechnologies launching new hardware to make single-cell barcoding more customisable. 🧬𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀 & 𝗲𝗽𝗶𝗴𝗲𝗻𝗼𝗺𝗶𝗰𝘀: 𝘴𝘤𝘢𝘭𝘦 𝘮𝘦𝘦𝘵𝘪𝘯𝘨 𝘴𝘰𝘱𝘩𝘪𝘴𝘵𝘪𝘤𝘢𝘵𝘪𝘰𝘯. From the launch of the Billion Cell Atlas by Illumina, to Genyro Inc. securing exclusive rights to Sidewinder™ and REPROCELL launching StemEdit, this space is clearly maturing fast. 🔬𝗣𝗿𝗼𝘁𝗲𝗼𝗺𝗶𝗰𝘀: 𝘴𝘦𝘯𝘴𝘪𝘵𝘪𝘷𝘪𝘵𝘺 𝘢𝘯𝘥 𝘢𝘤𝘤𝘦𝘴𝘴𝘪𝘣𝘪𝘭𝘪𝘵𝘺 𝘢𝘳𝘦 𝘤𝘰𝘯𝘷𝘦𝘳𝘨𝘪𝘯𝘨. Nicoya is making SPR-quality binding kinetics more accessible, Spear Bio is pushing multiplexing without sacrificing sensitivity, Nautilus Biotechnology opened early access to its single-molecule proteomics platform and Aventix announced its SCARLETT 01 benchtop volume analytics system. 🧠 𝗔𝗜, 𝘀𝗼𝗳𝘁𝘄𝗮𝗿𝗲 & 𝗱𝗮𝘁𝗮: 𝘴𝘩𝘪𝘧𝘵𝘪𝘯𝘨 𝘧𝘳𝘰𝘮 𝘩𝘺𝘱𝘦 𝘵𝘰 𝘶𝘴𝘢𝘣𝘭𝘦, 𝘳𝘰𝘣𝘶𝘴𝘵 𝘪𝘯𝘧𝘳𝘢𝘴𝘵𝘳𝘶𝘤𝘵𝘶𝘳𝘦. Evidation is enabling longitudinal multiomics studies with temporal biospecimen collection, while Elucidata is tackling one of the hardest problems in the field: making AI reliable on messy, real-world biological data. 🧪 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 & 𝘁𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻: 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘪𝘴 𝘮𝘰𝘷𝘪𝘯𝘨 𝘤𝘭𝘰𝘴𝘦𝘳 𝘵𝘰 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴. Watchmaker Genomics is strengthening point-of-care molecular workflows, while NanoMosaic Inc. and Truvian show how advanced platforms are progressing through regulatory and clinical adoption. 𝗕𝗶𝗴 𝗽𝗶𝗰𝘁𝘂𝗿𝗲? The common thread is better biology, in more practical workflows, at real-world scale — and a lot of that momentum is coming from focused, fast-moving teams. This is just a snippet of what happened in January, for more detail, see my full news breakdown. 🧬 #Biotech #LifeSciences #SingleCell #Proteomics #Genomics #Diagnostics #AIinBiology #BiotechTools #Startups

38

4 Comments

🚨 Tech Recruiters Who Move Fast & Hunt Like Detectives — This One’s Special 🚨 I don’t post opportunities lightly, but this one deserves the spotlight. Layer Health - a GV-backed, Series A health tech company - is doing deeply meaningful work at the intersection of AI and healthcare. Their mission? Unlocking the full potential of clinical data to transform how care is delivered. It’s important, technically ambitious, and impactful. The team is exceptional and they’re building something that matters. They need a contract Technical Recruiter who can jump in quickly and build momentum: • You move with urgency • You operate like a talent detective • You know how to engage top-tier engineers and technical talent • You care about mission-driven work This isn’t a “post and pray” role. This is a sleeves-rolled-up, sourcing-heavy, high-impact opportunity working alongside a smart, kind, ambitious team. If you’re a technical recruiter who thrives in early-stage environments and wants your work to matter - or you know someone who fits that bill - hit me up.

40

3 Comments

“AI Can Help You Write Better Performance Reviews — If You Use It Right” It's that dreaded time of year.... Year-End Performance Review season. Cue the coffee, the sighs, and the blinking cursor on that empty “Manager Comments” box. Here’s the thing: AI can help — but not by writing the whole thing for you. Used well, it’s your thinking partner… not your ghostwriter. Here’s how smart managers are using it (and how you can too): 🧠 1️⃣ Summarize your notes efficiently ✅ What to plug in: “Summarize these performance notes into key strengths and development themes: [paste 3–4 bullet points or meeting notes].” 🤖 AI output: “Strengths: strong project delivery, proactive communication. Development: prioritize workload and delegate effectively.” 💡 How to use it: Start with your observations. Let AI help organize and spot themes — not invent them. 📊 2️⃣ Turn data into impact statements ✅ What to plug in: “Help me write a results-based performance summary for an employee who increased process efficiency by 22% and mentored two new team members.” 🤖 AI output: “Delivered measurable operational improvements by streamlining workflows (22% efficiency gain) while building team capability through mentorship.” 💡 How to use it: Keep the metrics real. AI can refine your phrasing, but you provide the facts. 🗣️ 3️⃣ Check tone and clarity ✅ What to plug in: “Reword this feedback to sound constructive and encouraging, not overly critical: [paste paragraph].” 🤖 AI output: “You’ve made great progress improving collaboration; let’s build on that momentum by aligning earlier with cross-functional teams.” 💡 How to use it: AI can help you balance tone — especially if you tend to sound too blunt or too vague. ⚖️ 4️⃣ Spot bias and language drift ✅ What to plug in: “Review this feedback for potential gender or bias language.” 🤖 AI output: Highlights subjective phrases like “seems emotional” or “not assertive enough” and suggests neutral alternatives. 💡 How to use it: Use AI as a bias check, not a verdict — always review the suggestions yourself. ✨ Recommended Tools ChatGPT (Hi 👋) – great for structure, tone, and feedback phrasing. Notion AI – excellent for summarizing notes and finding performance patterns. Claude.ai – strong at rewriting for clarity and empathy. Wordtune or GrammarlyGO – solid for polishing tone and readability. AI won’t make your feedback meaningful — you will. Let it handle the formatting, flow, and polish so you can focus on what matters: giving real, thoughtful, human-centered feedback. #HRReinforced #AIinHR #PerformanceReviews #LeadershipDevelopment #FutureOfWork

4

2 Comments

Fierce Biotech's latest layoff tracker for 2025 paints a somber picture 📉. As the annual layoffs continue to climb, it's clear the biotech sector is navigating turbulent waters. Key Points: - 2025 Layoffs Rising: The trend persists, highlighting the volatility in the biopharma industry. - First Casualty of 2026: Nido Biosciences is winding down after disappointing study results, affecting a small number of employees. This underscores the industry's unpredictability and the pressing need for supportive transitions for those impacted. #Biotech #layoffs #IndustryTrends

3

1 Comment

Inside BioFire🔥- Culture, Growth and the Rocket Ship ride with Rachel Jones This week on Diagnosing Dx, I’m joined by Rachel Jones, former Chief Commercial Officer at BioFire Diagnostics, LLC and now at VedaBio. Rachel shares her remarkable journey from bench scientist to helping rebrand Idaho Technology into BioFire, scaling its commercial team from just 12 people into a billion-dollar diagnostics powerhouse, and ultimately shaping one of the most iconic success stories in infectious disease diagnostics.   We dig into the culture, growth, and lessons that defined BioFire’s rise, and what it takes to balance scientific innovation with commercial execution in a fast-changing market.   🔥What You’ll Learn: • How Rachel transitioned from the lab to commercial leadership • Why integrating science and business is key to scaling diagnostics • The pivotal role of syndromic testing in BioFire’s success • Lessons from BioFire’s acquisition by BioMérieux and its cultural impact 🎧 Listen/watch now on: 🔹 YouTube: https://lnkd.in/erTTpRNg 🔹 Spotify: https://lnkd.in/evmmVKgy 🔹 Apple Podcasts: https://lnkd.in/essCivJp 🔔 If you want to be alerted of new Diagnosing Dx episodes straight to your email inbox sign up here: https://lnkd.in/eQ4cebZv

95

28 Comments